National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$51.75
add to cart

Rights & Permissions

topleft topright

Microbial Status and Genetic Evaluation of Mice and Rats: Proceedings of the 1999 US/Japan Conference (2000)
Institute for Laboratory Animal Research (ILAR)

Citation Manager

. "International Harmonization of Laboratory Animals." Microbial Status and Genetic Evaluation of Mice and Rats: Proceedings of the 1999 US/Japan Conference. Washington, DC: The National Academies Press, 2000.

Please select a format:

BibTeX EndNote RefMan


Page
96
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Microbial Status and Genetic Evaluation of Mice and Rats: PROCEEDINGS OF THE 1999 US/JAPAN CONFERENCE

ences in some experiments. For breeders: Understanding (1) the reasons quality is required for laboratory animals, (2) the necessity of using objective scientific evidence to evaluate colonies, and (3) which procedures to use to confirm the genetic quality of laboratory animals.

Finally, in animal experiments (especially safety studies) using closed colonies, I recommend collecting and preserving DNA or biochemical marker data for tests on animals (mice and rats) used in safety studies in the development process of a new drug. If the results obtained in a safety study show significant differences from those obtained in a previous study or from other institutions, the causes can be narrowed down to the following: techniques (such as method of administration), environment (such as food, including temperature and humidity), and/or animals (genetic differences between the colonies used in the studies). Techniques and environment are specified in the GLP, as mentioned; but for animals used in the studies, only the strain names remain. It is important to know the genetic composition of the individuals that comprise the colonies used in the studies if the data obtained are to be utilized effectively. I therefore recommend that the genetic test data obtained for the animals used in such studies be preserved for future reference.

REFERENCES

Katoh, H., S. Wakana, M. Ebukuro, and T. Nomura. 1998. Existence of outbred substocks demonstrated using genetic monitoring system. Rat Genome 4:120-125.

Nomura, T., K. Esaki, and T. Tomita, eds. 1984. ICLAS Manual for Genetic Monitoring of Inbred Mice. Tokyo: University of Tokyo Press.

Page
96
Front Matter (R1-R16)
Opening Remarks, Judith Vaitukaitis (1-3)
Opening Remarks, Shin-Ichi Ota (4-5)
Introductory Comments on Microbiologic Testing of Laboratory Mice and Rats: Uniformity of Results (6-6)
Development of a Performance Assessment Program for Research Animal Diagnostic Laboratories and Defining Microbiologic Testing Standards (7-10)
Standardization of Rodent Health Surveillance: Regulation Versus Competition (11-15)
Factors Causing Difficulties in Uniformity of Results Among Testing Facilities in Microbiologic Monitoring of Laboratory Animals (16-20)
Necessity of Reexamining the Pathogenicity and Elimination of Parasites in Rats and Mice (21-26)
Emerging (and Reemerging) Viruses of Laboratory Mice and Rats (27-34)
Emerging Infections as a Cause of Concern (35-39)
Emerging Diseases in Mice and Rats (40-43)
Survey of Heliobacter Species in Laboratory Mice and Gerbils in Japan (44-46)
Genetic Evaluation of Outbred Rats (47-50)
Genetic Evaluation of Outbred Rats from the Breeder's Perspective (51-64)
Concept for Establishment of Rat Outbred Global Standard Strains (65-76)
Necessity of Genetic and Microbiologic Quality Network from the Pharmaceutical Industry's Perspective (77-84)
International Harmonization of Laboratory Animals (85-96)
Rat Genetics and Toxicology (97-104)
A Phenotype-driven Approach to the Molecular and Functional Analysis of the Mouse Genome (105-115)
Evaluation of Targeted Mutations (116-118)
Defining Behavioral Phenotypes in Transgenic and Knockout Mice (119-129)
Defining Phenotype in Genetically Engineered Mice (130-131)
Development of the Mouse Model Dramatype for Human Clinical Benefit (132-136)
Concluding Remarks (137-137)
Implication of Wild-derived Genes, Mitochondria, and Chromosomes in the Genetic Background of Mouse Models for Diseases and Biologic Functions (138-141)
Concluding Comments, John Strandberg (142-143)
Concluding Remarks, John Vandenbergh (144-146)
Appendix A (147-148)
Appendix B (149-150)